Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Capital Surplus	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss), net	Treasury Stock
Balance Beginning at Dec. 31, 2023	$ 1,968,104	$ 39	$ 156,076	$ 2,343,747	$ (503,861)	$ 5,837	$ (33,734)
Net Income (Loss)	22,117				22,117
Stock-based compensation expense	3,321			3,321
Stock-based compensation distributed	(144)		256	(256)			(144)
Stock issued for incentive compensation	2,302		189	3,166			(1,053)
Common stock issued as compensation to interim CEO	55		3	52
Common stock and Series B Preferred Stock dividends declared	(7,994)				(7,994)
Common stock issued for 401(k) match	2,322		122	2,200
Common stock issued to directors	770		37	733
Common stock issued under ATM Program	1,103		62	1,041
Other comprehensive income (loss)	(11,891)					(11,891)
Balance Ending at Jun. 30, 2024	1,980,065	39	156,745	2,354,004	(489,738)	(6,054)	(34,931)
Balance Beginning at Mar. 31, 2024	1,958,630	39	156,447	2,350,249	(513,608)	434	(34,931)
Net Income (Loss)	27,870				27,870
Stock-based compensation expense	2,157			2,157
Stock-based compensation distributed			205	(205)
Common stock issued as compensation to interim CEO	55		3	52
Common stock and Series B Preferred Stock dividends declared	(4,000)				(4,000)
Common stock issued for 401(k) match	1,071		53	1,018
Common stock issued to directors	770		37	733
Other comprehensive income (loss)	(6,488)					(6,488)
Balance Ending at Jun. 30, 2024	1,980,065	39	156,745	2,354,004	(489,738)	(6,054)	(34,931)
Balance Beginning at Dec. 31, 2024	2,039,514	39	160,052	2,418,149	(493,529)	(10,266)	(34,931)
Net Income (Loss)	86,577				86,577
Stock-based compensation expense	3,889			3,889
Stock-based compensation distributed	(885)		287	(287)			(885)
Stock issued for incentive compensation	2,503		119	2,384
Common stock and Series B Preferred Stock dividends declared	(5,023)				(5,023)
Common stock issued for 401(k) match	2,605		121	2,484
Common stock issued to directors	1,034		41	993
Common stock issued under ATM Program	174,132		7,252	166,880
Other comprehensive income (loss)	5,687					5,687
Balance Ending at Jun. 30, 2025	2,310,033	39	167,872	2,594,492	(411,975)	(4,579)	(35,816)
Balance Beginning at Mar. 31, 2025	2,073,967	39	160,228	2,423,631	(467,168)	(7,832)	(34,931)
Net Income (Loss)	57,705				57,705
Stock-based compensation expense	1,953			1,953
Stock-based compensation distributed	(885)		287	(287)			(885)
Common stock and Series B Preferred Stock dividends declared	(2,512)				(2,512)
Common stock issued for 401(k) match	1,386		64	1,322
Common stock issued to directors	1,034		41	993
Common stock issued under ATM Program	174,132		7,252	166,880
Other comprehensive income (loss)	3,253					3,253
Balance Ending at Jun. 30, 2025	$ 2,310,033	$ 39	$ 167,872	$ 2,594,492	$ (411,975)	$ (4,579)	$ (35,816)